Events

Building capacities to integrate the gender dimension in research projects

This was 3 years ago

Location

Online

Programmes
Horizon Europe

As part of the EU-funded Gender-SMART project (H2020) this capacity building session will be organised, to learn how to best integrate the gender dimension into project management and research contents. 

Combining short presentations with hands-on sessions in sub-groups, this activity will briefly introduce the state of the play with regard to gender imbalances in research and academic organizations, discuss the notions of gender blindness and gender bias in knowledge production, and provide practical guidance to enhance participants’ ability to mainstream a gender perspective.

You can read more about the session and register here

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.